A valid business license is required. Must be a professional healthcare provider or pharmaceutical product distributor to private label this product. 

Mometasone furoate 0.1% and hydroquinone is an anti-acne acne scar pigment clarifying combination formula. FDA approves it for treating mild to moderate inflammatory acne vulgaris in adolescents aged 18 years and above. The drug targets inflammatory acne lesions such as pigmentation, papules, pustules, and nodules triggered by excess inflammation in the skin. 

Mometasone furoate 0.1% with 2% natural hydroquinone is an anti-acne, acne scar, and pigment clarifying combination formula.  It acts as an effective bleaching agent and has been used commonly to lighten the skin.  The benefit of this formula over traditional hydroquinone skincare is a lack of rebound upon discontinuing, your skin remains the same, free from blemishes and breakouts. 

 Drug Status: Approved OTC Final Monograph

Packaging: 5oz/140ml pump (not available in other sizes and packaging)

Contact us for pricing and minimum quantity